Pepticom’s New Spinout Company, PeptiCov, to Focus on COVID-19
Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2…
Continue Reading
Pepticom’s New Spinout Company, PeptiCov, to Focus on COVID-19